DRTS
Alpha Tau Medical Ltd.
$10.88
▼ -2.60%$10.88▲ +275.17%
over 1Y
L $2.90EODHDH $11.18
Today-2.6%
1W+8.5%
1M+5.7%
3M+58.6%
YTD+125.3%
1Y+275.2%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 11 analysts
Buy
Conservative balance sheet (liabilities/equity 0.37x).
Alpha Tau Medical Ltd. shows limited reported revenue, and -55.3% ROE.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$13.8M | -$32.1M | -$35.7M | -$36.0M | -$42.3M |
| Net income | -$27.3M | -$33.8M | -$29.2M | -$31.8M | -$42.6M |
| Diluted EPS | -$0.67 | -$0.53 | -$0.42 | -$0.45 | -$0.53 |
| Net margin | — | — | — | — | — |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$951M
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-4.5%
FCF yield-3.4%
Quality & risk
ROIC (est.)-40.6%
Free cash flow-$32.8M
Total debt$5.25M
Net cash$6.95M
Piotroski F-Score2/6
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+25.0%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Recent filings
all on EDGAR ↗4Period ending 2026-06-252026-06-26open ↗144Filing2026-06-26open ↗6-KPeriod ending 2026-06-252026-06-25open ↗4Period ending 2026-06-232026-06-25open ↗6-KPeriod ending 2026-06-232026-06-23open ↗144Filing2026-06-23open ↗6-KPeriod ending 2026-06-112026-06-11open ↗4Period ending 2026-06-032026-06-04open ↗144Filing2026-06-04open ↗6-KPeriod ending 2026-06-032026-06-03open ↗6-KPeriod ending 2026-06-012026-06-01open ↗6-KPeriod ending 2026-05-182026-05-18open ↗
Frequently asked
- Is Alpha Tau Medical Ltd. (DRTS) a buy?
- DRTS currently carries a Hold rating with 2/5 conviction, derived from its latest SEC filings. Conservative balance sheet (liabilities/equity 0.37x).
- What is Alpha Tau Medical Ltd.'s quality score?
- DRTS scores 35.46153846153846/100 (grade F) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001871321, latest 4 filed 2026-06-26) · EODHD · as of 6/27/2026, 7:52:53 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.